Skip to content
ENGLISH
FRANCAIS
Solutions
Drug Development Journey
Services Overview
Clinical Trial Operations
Protocol Development and Study Design
Feasibility and Study Start Up
Patient Recruitment
Project Management
Clinical Operations
Centralized Monitoring
Decentralized Clinical Trials (DCT)
Centralized eTMF
Medical Services
Government and Public Health Services
Biometrics
Biostatistics and Statistical Programming
Biostatistical Consulting
Clinical Data Management
Clinical Programming and Data Science
Clinical Pharmacology Modeling Simulation
Clinical Pharmacology Integrated Drug Development
Model Informed Dose & Drug Development (MIDD)
Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
DMPK and Translational Discovery and Development
Regulatory and Drug Development Consulting
Clinical Strategy
Nonclinical
Chemistry, Manufacturing, and Controls (CMC)
Regulatory Affairs
GxP Strategy Consulting
Publishing and Submissions
Medical Writing
Therapeutic Expertise
Therapeutic Expertise Overview
By Subject
Oncology and Hematology
Rare Diseases and Orphan Drugs
Infectious Disease and Vaccine
Cell and Gene Therapy
Central Nervous System
Autoimmune and Inflammation
Allergy and Asthma
By Phase
Company
About Us
History
News
Events
Leadership Team
Mission, Vision, Values
Resources
Resource Library
Blogs
Case Studies
Podcasts
Webinar
White Paper
Careers
Careers Overview
Job Listings
CRA Academy and Fellows Programs
Contact Us
Contact Us
Request for Proposal / Information
Menu
Solutions
Drug Development Journey
Services Overview
Clinical Trial Operations
Protocol Development and Study Design
Feasibility and Study Start Up
Patient Recruitment
Project Management
Clinical Operations
Centralized Monitoring
Decentralized Clinical Trials (DCT)
Centralized eTMF
Medical Services
Government and Public Health Services
Biometrics
Biostatistics and Statistical Programming
Biostatistical Consulting
Clinical Data Management
Clinical Programming and Data Science
Clinical Pharmacology Modeling Simulation
Clinical Pharmacology Integrated Drug Development
Model Informed Dose & Drug Development (MIDD)
Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
DMPK and Translational Discovery and Development
Regulatory and Drug Development Consulting
Clinical Strategy
Nonclinical
Chemistry, Manufacturing, and Controls (CMC)
Regulatory Affairs
GxP Strategy Consulting
Publishing and Submissions
Medical Writing
Therapeutic Expertise
Therapeutic Expertise Overview
By Subject
Oncology and Hematology
Rare Diseases and Orphan Drugs
Infectious Disease and Vaccine
Cell and Gene Therapy
Central Nervous System
Autoimmune and Inflammation
Allergy and Asthma
By Phase
Company
About Us
History
News
Events
Leadership Team
Mission, Vision, Values
Resources
Resource Library
Blogs
Case Studies
Podcasts
Webinar
White Paper
Careers
Careers Overview
Job Listings
CRA Academy and Fellows Programs
Contact Us
Contact Us
Request for Proposal / Information
Search
Search
Search
Search
Home
|
Resources
Resources
All Topics
Allergy
Autoimmune and Inflammation
Biomarkers
Biometrics
biostatistics
Cardiovascular
Cell and Gene Therapy
Central Nervous System
Centralized Monitoring
Chemistry, Manufacturing, and Controls (CMC)
Clinical Pharmacology Modeling and Simulation
Clinical Trial Operations
Covid-19
Data Management
Decentralized Clinical Trials
Depression
Dosing
Drug Development
Emerging Trends
Gastroenterology and Hepatology
Infectious Disease and Vaccine
Inspection Readiness
Manufacturing
Medical Writing
Nonclinical
Oncology-Hematology
Other
Patient Recruitment
Pediatric
Pharmacokinetics/Pharmacodynamics
Pharmacovigilance
Preclinical
Preclinical Development
Project Management
Protocol Development and Study Design
Publishing and Submissions
Rare Disease and Orphan Drugs
Regulatory
Regulatory Affairs
regulatory and drug development consulting
Study Startup and Feasibility
All Type
Blog
Brochure
Case Study
Guide
Industry Featured Article
Podcast
Poster
Presentation
Uncategorized
Webinar
White Paper
Industry Featured Article
Translating Complex Data into Actionable Insights, to Create Big Value for Smaller Biotech Companies
Read More
Webinar
Clinical Pharmacology Studies to Support Filing Packages and Labeling
Read More
Blog
Sifting Through Rarity: Advanced Patient Screening for Rare Disease Trials
Read More
Case Study
Using PBPK to Predict CSF and Brain Exposure of CNS Penetrant Drugs
Read More
Blog
Mastering Clinical Trial Design: Will FDA’s Latest Guidance on Master Protocols Encourage Increased Adoption?
Read More
Case Study
Unleashing the Power of Predictive Modeling: A Journey to Safe and Effective Dosing for a CNS Drug
Read More
Webinar
Risk Assessment of Novel Therapeutics: Mechanistic Translation of Preclinical Safety and PK/PD Data to a Clinical Setting
Read More
Blog
Fast-Tracking Drug Development: Role of Mechanistic PK/PD Modeling
Read More
Industry Featured Article
Advancing Excellence in Clinical Programming Solutions
Read More
Blog
Balancing Act in Preclinical Development: Strategies for Assessing and Managing Neurotoxic Risks in CNS Therapeutics
Read More
Blog
Cell & Gene Therapy Advancements: Early-Stage CMC Strategies for Exosome Innovation
Read More
Industry Featured Article
The Role of Statisticians in Study Design and Why to Engage Them Early
Read More
Industry Featured Article
Navigating the Challenges of Clinical Trial Design
Read More
Webinar
Efficient Clinical Programs and Decision Making Through Model-Informed Drug Development (MIDD)
Read More
Webinar
Pediatric Clinical Trials: Tackling Clinical and Therapeutic Development Challenges Head-On
Read More
Blog
Anti-Depression Medication: Current Landscape and Product Development Trends
Read More
Blog
Advancing Oncology Drug Development: The Importance of Single-Arm Trials
Read More
Industry Featured Article
A Journey of Collaboration and Future Transformations in Biotech Space
Read More
Industry Featured Article
Patient-Centric Approach To Accelerating Clinical Trials
Read More
Webinar
More than Skin Deep: Considerations for Dermatology and Drugs Administered to the Skin
Read More
Webinar
PBPK Modeling for Pediatric Drug Development
Read More
Blog
Inroads To Approval: Navigating Formal FDA Meetings to Optimize Your Drug Development Program
Read More
Blog
Exosomes: Unveiling Their Potential in Cell and Gene Therapy
Read More
Brochure
Technical Writing Services with a Clinical Pharmacology Focus
Read More
Brochure
Study Design and Conduct Leveraging Allucent's Clinical Pharmacology Expertise
Read More
Brochure
Population Modeling Capabilities
Read More
Brochure
Model-Informed Drug Development
Read More
Brochure
Begin with the End in Mind Investigational New Drug (IND) Services
Read More
Brochure
Allucent's Expertise in Predicting Human Exposure From Nonclinical Data
Read More
Brochure
505(b)(2) Regulatory Pathway - Clinical Pharmacology Services
Read More
Case Study
Using PBPK to Optimize Magnesium Concentrations in an Intravenous Formulation
Read More
Case Study
Using PBPK to Extrapolate Animal Tissue Concentrations to Humans
Read More
Case Study
Using Modeling and Simulation to Determine FIH Dose
Read More
Case Study
Gene Therapy
Read More
Case Study
Due Diligence to Support a Client’s Decision-Making
Read More
Case Study
Complex Concentration-QT Analysis
Read More
Brochure
Industry Featured Article
Rare Central Nervous System Disease Trials
Read More
Blog
Series on Cannabis and Cannabis-Derived Products for Therapeutic Development, Part One
Read More
Blog
The Office of Therapeutic Products (OTP): A New Way Forward for Cell and Gene Therapies
Read More
Blog
Nonhuman Primates (NHPs): FDA Issues Guidance for Use in Nonclinical Safety Studies
Read More
Blog
Stepwise Paediatric Investigation Plan — Evolutionary or Revolutionary?
Read More
Blog
FDA Clarifies Policy on Post-COVID Meetings
Read More
Blog
Let's Extrapolate!
Read More
Guide
Guide to CTIS Workspace Organization
Read More
Blog
Overcoming Patient Recruitment Difficulties in Acute Ischemic Stroke Trials
Read More
Guide
Biometrics Fact Sheet
Read More
Blog
Lessons Learned as Early Adapters of the EU’s Clinical Trials Regulation
Read More
Blog
Diversity in clinical trials: Optimizing drug development strategy, leveraging data and increasing efficiency with modeling and simulation.
Read More
Blog
How to Overcome Challenges in Combination Immunotherapy Clinical Trials
Read More
Guide
When should you incorporate CPMS?
Read More
Podcast
Operationalizing Cell and Gene Therapy Trials
Read More
Podcast
Why Multinational Clinical Trials are Key to Bringing Novel Therapies to Patients
Read More
Podcast
Defining the Regulatory Roadmap for Product Success
Read More
Industry Featured Article
Spotlight on oncology drug development and its future
Read More
Industry Featured Article
Focusing on smaller biotechs to have a big impact on society
Read More
Industry Featured Article
Big passion for small biotech and its potential to address complex diseases
Read More
Industry Featured Article
When it comes to small populations, biotechs need to think big
Read More
Guide
5 Areas Where a Biostatistician Can Help
Read More
Guide
A Guide to Scientific Advice
Read More
White Paper
Citeline Report - Executing Early Phase Research In Hematological Oncology: What Matters To Biotech?
Read More
Blog
Developing CNS Neurotherapeutics with Cerebrospinal PK/PD Clinical Studies
Read More
Blog
Accelerating Drug Development of Innovative Oncologic Agents: Master Protocols
Read More
Blog
Long-Term Follow-Up for CGT Trials: Best Practices to Operationalize
Read More
Blog
What is Pharmacodynamics?
Read More
Blog
The Role of Statisticians in Study Design and Why to Engage them Early
Read More
Webinar
Benefits of Bayesian Dose Escalation Designs for Oncology Studies
Read More
Webinar
Risk Assessment: Traditional and Novel Approaches to Assess and Manage Risks
Read More
Guide
A Snapshot of Gap Analysis
Read More
Blog
Risk Assessment: Traditional and Novel Approaches
Read More
Blog
The Role of Clinical Pharmacology in New Drug Development
Read More
Blog
Gap Analysis: The Benefit of Conducting Technical and Regulatory Due Diligence
Read More
Industry Featured Article
Allucent Scientists Author Top Downloaded Journal Article in Clinical Pharmacology & Therapeutics in 2021
Read More
Guide
3 Tips for IMPD Success
Read More
Blog
What is Clinical Pharmacology?
Read More
Blog
Smarter Drug Development for Rare Diseases
Read More
Case Study
Grass & Birch Allergy Phase II Parallel Studies
Read More
Blog
The Essential Role of the CMC Expert in Drug Development
Read More
Blog
Rare Disease Research – Why We Do What We Do
Read More
Blog
A Regulatory Perspective on Cell and Gene Therapy in Oncology
Read More
Webinar
Inspection Readiness: What is it, why it matters, and what you need to know to be prepared
Read More
Blog
Inspection-Readiness: What You Need to Know to Prepare for a GCP Inspection
Read More
Blog
Leveraging Modeling & Simulation for Pediatric Drug Development
Read More
Blog
Developing Oligonucleotide Therapies
Read More
Blog
What is Pharmacokinetics and ADME?
Read More
Blog
Optimizing Trial Efficiency with Bayesian Dose Escalation Designs
Read More
Blog
Understanding How PK Data and CDISC Work Together
Read More
Blog
The Potential of Biosimilars – for Drug Makers and Patients
Read More
Blog
The Multifaceted Role of the Nonclinical Expert at the Center of Drug Development Teams
Read More
Blog
The Black Box of Anti-COVID-19 Monoclonal Antibodies: An Overview, Definitions, and Terminology
Read More
Blog
Expediting Treatments to Oncology Patients in Need: Understanding the FDA’s Accelerated Pathways
Read More
Blog
Common Clinical Pharmacology Mistakes to Avoid in Drug Development
Read More
Blog
Compartmental Modeling in Pharmacokinetics
Read More
Webinar
Navigating Regulatory Strategies for Cellular & Gene Therapies
Read More
Blog
Determining First-in-Human (FIH) Dose for Clinical Studies
Read More
Blog
Introduction to Healthcare-Associated Infections (HAIs)
Read More
Blog
How to Use Modeling and Simulation to Optimize a 505(b)(2) Application
Read More
Blog
Benefits of Using Modeling and Simulation to Design and Interpret Phase 3 Clinical Trials
Read More
Blog
FDA Project Optimus: Selecting the Optimal Dose for Oncology Therapeutics
Read More
Blog
The Case for Early Regulatory Consideration for Clinical Development of Chimeric Antigen Receptor T cell (CART)
Read More
Blog
How to Form a Clinical Pharmacology Strategy for your NDA, BLA, or MAA
Read More
Blog
Great News from EMA in December: Three New Treatments for COVID-19
Read More
Industry Featured Article
Long-Standing Partnerships: Immutep's CEO, Marc Voigt in an interview for CEO Magazine
Read More
Blog
Cervical Health Awareness Month - Cervical Cancer: Prevention, Detection, Development
Read More
Blog
Pharmacokinetic Parameters in Drug Development
Read More
Blog
Adaptive Design Considerations for Early Phase Oncology Trials
Read More
Case Study
Indolent NHL Immuno-Oncology Rescue Study
Read More
Blog
Respiratory Viral Infections: Progress and Innovation
Read More
Blog
Understanding Long-Haul COVID
Read More
Blog
The Role of Liquid Biopsies in the Clinical Trial Setting
Read More
Blog
What are Good Laboratory Practices (GLP) for Nonclinical Studies?
Read More
Blog
Benefits of Utilizing the 505(b)(2) Pathway for Prodrugs
Read More
Blog
Understanding CDISC SEND Data and How to Be Compliant
Read More
Blog
Important Milestones in Infectious Diseases Clinical Trials: A Timeline of Infectious Disease Research
Read More
Blog
Infectious Disease Research: Importance of Site Location in Clinical Trials
Read More
Blog
EU Clinical Trial Regulation: What, When, Who, Why, How?
Read More
Blog
Leveraging Autoimmune Therapies in Infectious Disease and Vaccine Research
Read More
Blog
Pre-IND Meeting Guide: Benefits & How to Prepare
Read More
Blog
Autoimmune Clinical Trials: A Brief Review of Recent Autoimmune Research
Read More
Blog
Important Milestones in Autoimmune Research: A Timeline of Autoimmunity
Read More
Blog
Better Clinical Trials: How Does Location Impact Autoimmune Research Studies?
Read More
Blog
When Should You Hire a Clinical Pharmacologist?
Read More
Blog
Autoimmune Research in Review: Microbiome, Microbiota, and Immune System Conditions
Read More
Webinar
Roadmap To Marketing Authorisation in Europe: Taking All the Right Turns
Read More
Blog
What Is CDISC and What Are CDISC Data Standards?
Read More
Blog
Allergy Clinical Trials: Recent Asthma and Allergy Research in Review
Read More
Blog
FDA Orphan Drug Designation for Rare Diseases
Read More
Blog
Important Milestones in Allergy Research and Clinical Trials: A Timeline
Read More
Blog
Site Location Selection: Key to Conducting Better Allergy Clinical Trials
Read More
Blog
Allergy Immunotherapy in Review: New Developments in Immune Therapy
Read More
Blog
Common Misconceptions About PBPK Modeling
Read More
White Paper
Mind the Gap: The Importance of Gap Analysis in Securing Regulatory Approval
Read More
Blog
Cancer Clinical Trials: Recent Oncology Research Studies in Review
Read More
Blog
Anticipating Obstacles to Approval Before Your Early Phase Oncology Study: Four Critical Areas to Consider
Read More
Blog
How to Choose Sites for Cancer Trials: Central and Eastern Europe
Read More
Blog
CAR T-Cell Therapy Challenges to Development & Approval
Read More
Blog
Clinical Trials Today: Recent Milestones in Rare Cancer Research
Read More
Blog
What is a 505(b)(2)?
Read More
Blog
Conducting Clinical Trials in Rare Oncology
Read More
Blog
Rare Disease Research in Central and Eastern Europe
Read More
Blog
Understanding the Importance of Location in Rare Disease Studies
Read More
Presentation
Managing Clinical Trial Risk Strategically: Collaborating for Success With Your Outsourcing Partners
Read More
Blog
Impact of COVID-19 on Rare Disease Research
Read More
Blog
Common Misconceptions About QSP Modeling
Read More
Blog
Challenges to Research in the Age of COVID
Read More
Blog
Cost-Effective Techniques for Creating QSP Models
Read More
Blog
When Will Patients Return? The COVID Impact
Read More
Blog
EMA & FDA Approvals and Recommendations in 2020 for Oncology Drugs and Diagnostics/Devices
Read More
Blog
What's Happening in Ulcerative Colitis Trials Right Now?
Read More
Blog
Understanding Current and Future Therapeutic Options for COVID-19
Read More
Blog
8 Strategies for Navigating Clinical Studies During COVID-19
Read More
Blog
6 Tools Used To Achieve a Clean & Reliable Database Lock
Read More
Blog
What is Earned Value Management and Why Use It at a CRO?
Read More
Blog
Fostering Inclusion and Diversity in Clinical Trials
Read More
Webinar
Webinar | Pharmacogenomics and Pediatric Drug Development: When Are Children Not Little Adults and Why?
Read More
Blog
Risk Management: Your Foundation for Better Project Management
Read More
Blog
Clinical Highlights from the First Virtual European Society for Medical Oncology Congress
Read More
Blog
Strategizing for Your Submission: Planning Ahead for Your NDA or BLA
Read More
Blog
What is the Difference Between Microbiome and Microbiota?
Read More
Blog
Understanding the Connection Between COVID-19 and VAP
Read More
Blog
Current and Emerging Therapies for Patients With Multiple Myeloma
Read More
Blog
The Role of Pre-Clinical Pharmacokinetics in Early Drug Development
Read More
Webinar
Next Generation Strategies for Orphan Drug Development
Read More
Blog
Improving Informed Consent in Clinical Trials
Read More
Blog
Understanding the 3 Types of Clinical Trial Monitoring
Read More
Blog
New FDA Guidance for October 2020 and Upcoming Advisory Committee Meetings
Read More
White Paper
Current Trends in the Clinical Development of Combination Therapies with Immune Checkpoint Inhibitors
Read More
Blog
Cellular & Gene Therapy: Implications on Drug Development
Read More
Blog
PBPK Modeling & Simulation in Drug Development
Read More
Blog
New FDA Guidances for August 2020 and Upcoming Advisory Committee Meetings
Read More
Webinar
The Challenges of Cancer Immunotherapy Development and Ensuring Durability of Response
Read More
Blog
The Importance of Natural History Study to Rare Disease Drug Development
Read More
Blog
Allucent’s Audit-Ready Approach to Database Build
Read More
Blog
The Importance of Clinical Trial Transparency for Drug Development
Read More
Blog
Current Trends in Systemic Lupus Erythematosus (SLE) Trials
Read More
Blog
The COVID 19 Map per ClinicalTrial Gov
Read More
Blog
How to Avoid Clinical Trials Using Modeling & Simulation
Read More
Blog
New FDA Guidances for July 2020 and Upcoming Advisory Committee Meetings
Read More
Blog
Allucent Releases Updated Paper on the Impact of COVID on Clinical Research
Read More
Blog
Benefits & Uses of QSP in Drug Development
Read More
Webinar
The Value of Orphan Drug Designation in your Drug Development Program
Read More
Blog
Immuno-Oncology Updates in the Virtual Era - ASCO 2020
Read More
White Paper
Advancing Cancer Vaccines to the Forefront of Immunotherapy
Read More
Blog
6 Study Adaptations to Keep Studies Moving Despite COVID-19 Pandemic
Read More
Blog
Managing Patient Enrollment in Acromegaly Rare Disease Studies
Read More
Blog
New FDA Guidances for June 2020 and Upcoming Advisory Committee Meetings
Read More
Blog
Brexit is Here - Is Your Clinical Trial Ready?
Read More
Blog
Are You Ready for the New European Clinical Trial Regulation?
Read More
Webinar
Future Proofing Inflammatory Bowel Disease Diagnosis & Clinical Trials
Read More
Blog
Clinical Research Regulation in the Netherlands
Read More
Blog
The Benefits of Conducting Clinical Research in Russia
Read More
Blog
Current Trends in Allergy Immunotherapy
Read More
Webinar
Advancing Cancer Vaccines to Move to the Forefront of Immunotherapy
Read More
Blog
Medical Data Reviewer: Allucent's Secret to Study Success
Read More
Blog
Challenges Working with Terminally-Ill Patients in an International Rare Disease Study
Read More
Blog
Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger
Read More
Blog
How Technology Makes Virtual Clinical Pharmacology Phase 1 Studies Possible
Read More
Blog
Complexities of Combining Adults into Protocol with Pediatrics and Adolescents
Read More
Webinar
Pre-Anticipation: Anticipating Obstacles to Approval Before Phase I in Oncology Drug Development
Read More
Blog
How Rave CSA Supports Remote Monitoring in COVID-19
Read More
Blog
Points to Consider in Drug Development of Biologics and Small Molecules
Read More
Blog
Conducting Clinical Trials in South Africa: A Revitalized Environment
Read More
Blog
What’s New Health Canada?
Read More
Blog
DISCOVER 360: Allucent’s Comprehensive Approach to Site Selection
Read More
Webinar
Maintaining Momentum: Applying Recent Regulatory Guidance in the Midst of the Coronavirus
Read More
Blog
Allergy Immunotherapy in Adult and Pediatric Subjects with Peanut Allergy
Read More
Blog
Cancer, COVID-19, Continuity
Read More
Blog
Consideration for Ongoing Clinical Trials: Ensuring Participant Safety and Adapting New Processes during COVID‑19 Pandemic
Read More
Blog
What is Toxicokinetics (TK)?
Read More
Blog
Understanding the New Asthma Guidelines
Read More
Blog
What are the Regulatory Differences Between an NDA and BLA?
Read More
Blog
Multicenter Phase III Study Efficacy of mAb Treatment for Ventilator-Associated Pneumonia (VAP)
Read More
Blog
Ethically Consenting Patients in Ventilator-Associated Studies
Read More
Blog
The Future of Rare Disease Research
Read More
Blog
When to Use 505(b)(1) & 505(b)(2) Pathways for New Drugs and Common Misconceptions
Read More
Blog
The Use of Drug Repurposing in Rare Disease Research
Read More
Blog
Phase I Oncology PD-1 Inhibitor Enrolled 78 Days Early
Read More
Blog
The Use of Gene Therapies in Rare Disease Research
Read More
Blog
The Use of Oligonucleotide Therapies in Rare Disease Research
Read More
Blog
The Use of Protein Replacement Therapies in Rare Disease Research
Read More
Blog
Effective Cohort Management in Early Phase Oncology Trials
Read More
Blog
The Use of Antibody Therapy in Rare Disease Research
Read More
Blog
Three Blockbuster Approved Cancer Drug Launches Expected in 2020
Read More
Blog
The Proposal Manager Necessity
Read More
Blog
Trends in Small Molecule Rare Disease Research
Read More
Blog
Key IND-Enabling Studies
Read More
Blog
Rare Disease Research and the Road Ahead
Read More
Industry Featured Article
Chronic Lymphocytic Leukaemia: Current and Emerging Treatment Options
Read More
Webinar
Enrollment, Enrichment, and Monitoring Strategies to Accelerate Phase 3 Clinical Trials in NASH
Read More
Blog
What are Adaptive Design Clinical Trials?
Read More
Blog
5 Common FDA Applications for Drugs & Biologics
Read More
Webinar
How Feasible is Feasibility in Clinical Trials?
Read More
Blog
What is Steady-State Concentration in Pharmacokinetics?
Read More
Blog
Lessons Learned From a Phase II Influenza Clinical Trial
Read More
Blog
Tissue-Agnostic Therapeutics and Biomarkers in Oncology
Read More
Blog
9 Tips for Preparing a Successful New Drug Application (NDA)
Read More
Blog
What are Real-World Data and How Can they Benefit Drug Development?
Read More
Blog
Risk Evaluation and Mitigation Strategy: Tipping the Balance for FDA Approval
Read More
Webinar
Getting your ducks in a row: Successful Management of Large eCTD Submissions
Read More
Blog
What is Allometric Scaling and How Does it Support Drug Development?
Read More
Blog
To the Rescue: A New Hope for Your Development Program
Read More
Blog
Completing a Rescue Study Transition - How Much Time Do You Need?
Read More
Blog
What is IVIVC?
Read More
White Paper
Journal for Clinical Studies: Combination Approaches in Immuno-Oncology Trials: New Horizons for Multiple Tumor Indications
Read More
Webinar
Mind the Gap(s): Early Identification of Issues is Key for a Successful NDA or BLA
Read More
Blog
Best Practices in Clinical Study Protocol Writing
Read More
Blog
Types of Marketing Exclusivity in Drug Development
Read More
Blog
What is a Human Mass Balance Study?
Read More
Blog
Importance of Natural History Studies to Rare Disease Drug Development
Read More
Blog
3 Rare Disease Challenges Overcome From A Recent Phase 3 Pivotal Study
Read More
Blog
5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials
Read More
Blog
Pharmacokinetics in Patients with Hepatic Impairment
Read More
Blog
Surrogate Endpoints – Neither the End nor the Point
Read More
Blog
How to Successfully Prepare for Your Pediatric Study Plan
Read More
Poster
Overview of immuno-oncology clinical trial conduct and design investigating combination therapies
Read More
Blog
What to Expect following Your Marketing Application Submission
Read More
Blog
New FDA Guidance on Natural History Studies for Rare Diseases
Read More
Blog
Dose Selection for Cellular and Gene Therapies
Read More
Blog
eCTD Regulatory Submissions: Hints & Common Mistakes to Avoid
Read More
Blog
Does the FDA Esketamine Approval Open the Door for Enrichment Trial Designs in Psychiatry?
Read More
Blog
Intrinsic and Extrinsic Factors in Drug Development
Read More
Blog
Let's Talk About Patient Engagement
Read More
Blog
Revised FDA Guidance on Developing Rare Disease Therapies
Read More
Blog
Pharmacogenetics - Tailoring Your Product to Fit the Genes
Read More
Blog
Draft Guidance of the Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products
Read More
Blog
Pharmacokinetic Considerations for Topical Medications
Read More
Blog
New Year New FDA Strategic Framework on Real World Evidence Program
Read More
Blog
The Path to IND Part 2: Supporting Clinical Study Design and Dosing
Read More
Blog
What is Population Pharmacokinetic (popPK) Analysis?
Read More
Blog
The Path to IND Part 1: Milestones & Common Roadblocks
Read More
White Paper
Journal for Clinical Studies editorial - Landscape of early-phase oncology studies in the Netherlands
Read More
Blog
Why Do Clinical Trials Fail?
Read More
Blog
What is the Difference Between ANDAs & 505(b)(2) NDAs?
Read More
Blog
Combination immunotherapy: The latest revolution in cancer treatment
Read More
Blog
What is Noncompartmental Pharmacokinetic Analysis?
Read More
Blog
What is Model-Informed Drug Development?
Read More
Blog
Metabolites: Formation, Identification, and Impact on Drug Development
Read More
Blog
What is the Difference Between PBPK and PopPK Modeling?
Read More
Blog
IND Requirements and Exemptions
Read More
Blog
New Meeting Opportunities with FDA through the Model-Informed Drug Development (MIDD) Pilot Program
Read More
Blog
Exception from Informed Consent in Emergency Research
Read More
Blog
Submitting IND Safety Reports using us-regional DTD v3.3 versus v2.01: What’s the Difference?
Read More
Blog
Understanding the Cost of Pharmacokinetic & Pharmacodynamic Analyses
Read More
Blog
What Are CAR T-Cell Therapies?
Read More
Blog
Monoclonal Antibodies: Past, Present and Future
Read More
Blog
Bioequivalence Studies to Support Abbreviated New Drug Applications
Read More
Blog
Pharmacokinetic Considerations for Repeat-Dosing
Read More
Blog
Compassionate Use: providing cancer care outside trials
Read More
Blog
Cancer Immunotherapy: A New Hope
Read More
Blog
A New Expedited Review Designation: Regenerative Advanced Therapy
Read More
Blog
Transparency Initiatives at Health Canada
Read More
Blog
Precision Medicine and the FDA
Read More
Blog
CIMT 2016 - Rise of mRNA therapeutics, a relatively new class of treatment
Read More
Blog
CIMT 2016 "Mechanisms of efficacy in cancer immunotherapy"
Read More
Poster
Comparison of Phase I/II trials regarding antigen-specific versus non-specific anticancer immunotherapies
Read More
Blog
Jump on the Development Safety Update Report (DSUR) Bandwagon!
Read More
Blog
The FDA Wants To Hear Patients’ Voices
Read More
Blog
PK/PD Analysis Potentially Eliminates the Need of a Thorough QT QTc Study
Read More
Blog
'Inhibit the inhibitor' - it's all about PD-(L)1 inhibitors in cancer treatment
Read More
Poster
Comparison of study designs, objectives and results of Phase I trials with cytotoxic versus non-cytotoxic anticancer agents
Read More
White Paper
Put to the Test
Read More
No posts found
1
2